BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36423586)

  • 21. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.
    Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH
    Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.
    Pang A; Hu Y; Zhou P; Long G; Tian X; Men L; Shen Y; Liu Y; Cui Y
    Cardiovasc Diabetol; 2015 Oct; 14():134. PubMed ID: 26446774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
    Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
    J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigallocatechin-3-gallate attenuates myocardial fibrosis in diabetic rats by activating autophagy.
    Jia Q; Yang R; Mehmood S; Li Y
    Exp Biol Med (Maywood); 2022 Sep; 247(17):1591-1600. PubMed ID: 35833541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model.
    Wu B; Huang XY; Li L; Fan XH; Li PC; Huang CQ; Xiao J; Gui R; Wang S
    J Cell Mol Med; 2019 Nov; 23(11):7651-7663. PubMed ID: 31565849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,25-Dihydroxyvitamin-D3 prevents the development of diabetic cardiomyopathy in type 1 diabetic rats by enhancing autophagy via inhibiting the β-catenin/TCF4/GSK-3β/mTOR pathway.
    Wei H; Qu H; Wang H; Ji B; Ding Y; Liu D; Duan Y; Liang H; Peng C; Xiao X; Deng H
    J Steroid Biochem Mol Biol; 2017 Apr; 168():71-90. PubMed ID: 28216152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell death-inducing DFFA-like effector C/CIDEC gene silencing alleviates diabetic cardiomyopathy via upregulating AMPKa phosphorylation.
    Zhou HM; Ti Y; Wang H; Shang YY; Liu YP; Ni XN; Wang D; Wang ZH; Zhang W; Zhong M
    FASEB J; 2021 May; 35(5):e21504. PubMed ID: 33913563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
    Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
    Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose radiation prevents type 1 diabetes-induced cardiomyopathy via activation of AKT mediated anti-apoptotic and anti-oxidant effects.
    Zhang F; Lin X; Yu L; Li W; Qian D; Cheng P; He L; Yang H; Zhang C
    J Cell Mol Med; 2016 Jul; 20(7):1352-66. PubMed ID: 26991817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginsenoside Rb1 alleviates chronic intermittent hypoxia-induced diabetic cardiomyopathy in db/db mice by regulating the adenosine monophosphate-activated protein kinase/Nrf2/heme oxygenase-1 signaling pathway.
    Bingbing L; Jieru LI; Jianchao SI; Qi C; Shengchang Y; Ensheng JI
    J Tradit Chin Med; 2023 Oct; 43(5):906-914. PubMed ID: 37679978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling.
    Ding W; Feng H; Li WJ; Liao HH; Zhang N; Zhou ZY; Mou SQ; Lin Z; Xia-He NZ; Xia H; Tang QZ
    Eur J Pharmacol; 2021 Oct; 909():174402. PubMed ID: 34348125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of Carvedilol on Cardiac Function and the AKT/XIAP Signaling Pathway in Diabetic Cardiomyopathy Rats.
    Zheng W; Shang X; Zhang C; Gao X; Robinson B; Liu J
    Cardiology; 2017; 136(3):204-211. PubMed ID: 27780169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
    Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
    Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
    J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin attenuates diabetic cardiomyopathy by increasing autophagy of cardiomyocytes via regulation of VEGF-B/GRP78/PERK signaling pathway.
    Zhang S; Tian W; Duan X; Zhang Q; Cao L; Liu C; Li G; Wang Z; Zhang J; Li J; Yang L; Gao Y; Xu Y; Liu J; Yan J; Cui J; Feng L; Liu C; Shen Y; Qi Z
    Cardiovasc Diabetol; 2024 Jan; 23(1):19. PubMed ID: 38195474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JinLiDa granules alleviates cardiac hypertrophy and inflammation in diabetic cardiomyopathy by regulating TP53.
    Fang T; Wang J; Sun S; Deng X; Xue M; Han F; Sun B; Chen L
    Phytomedicine; 2024 Jul; 130():155659. PubMed ID: 38759318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
    Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
    Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of PPARγ agonist pioglitazone on cardiac fibrosis in diabetic mice by regulating PTEN/AKT/FAK pathway.
    Zhang XD; Sun GX; Guo JJ; Hu CC; Sun RC; Yu HC
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):812-819. PubMed ID: 33577036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.